Hydroxychloroquine flunks Phase III trial in mild-to-moderate Covid-19

The study adds to the growing body of evidence that the drug, promoted early in the pandemic by President Trump, is ineffective, despite its getting a briefly renewed lease on life earlier this month thanks to a retrospective analysis.